DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 -13.64 -0.30%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo

Questcor Pharmaceuticals (NASDAQ: QCOR)

0.00 0.00 (0.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

QCOR $0.00 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $0.00
Daily Range $0.00 - $0.00
52-Week Range $47.71 - $97.80
Market Cap $0.00
P/E Ratio 16.36
Dividend (Yield) $1.20 (0.0%)
Ex-Dividend Date
Dividend Pay Date
Volume 0
Average Daily Volume 0
Current FY EPS $7.19





Questcor Pharmaceuticals (QCOR) Description

A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system. Website:

News & Commentary Rss Feed

Why I'm Still Avoiding Questcor

A total of seven litigations against Questcor are currently underway. Two of them - the Retrophin litigation and USAO litigation - represent very serious threats to the H.P. Acthar business model.

Anika Therapeutics: A Recent Greenblatt Small Cap Biotech Pick

10 best and worst S&P 500 stocks of 2014

Update: Questcor Shareholders Are The Net Gainers Of Acquisition Deal

Gulfmark Offshore (GFL) Now Added to S&P SmallCap 600 Index - Analyst Blog

Prem Watsa Buys 4 New Stocks

Retrophin CEO Under Fire for Twitter Faux Pas

Mallinckrodt Is Like Steak - Very Tasty

Paulson Bets Again On Mallinckrodt

Top Performing Funds Play Favorits

Questcor Seems To Lie By Omission To The SEC, Aetna National Medical Director Slams Acthar

See More QCOR News...

QCOR's Top Competitors

QCOR $0.00 (0.00%)
Current stock: QCOR
JNJ $107.99 (0.60%)
Current stock: JNJ
NVS $93.90 (-0.95%)
Current stock: NVS
RHHBY $37.64 (-0.70%)
Current stock: RHHBY